Comparison between PNGS Reva Diamond Jewellery IPO and Sudeep Pharma IPO.
PNGS Reva Diamond Jewellery IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sudeep Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of PNGS Reva Diamond Jewellery IPO is up to ₹379.52 Cr whereas the issue size of the Sudeep Pharma IPO is up to ₹895.00 Cr. The final issue price of PNGS Reva Diamond Jewellery IPO is ₹386.00 per share and of Sudeep Pharma IPO is ₹593.00 per share.
| PNGS Reva Diamond Jewellery IPO | Sudeep Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹367.00 per share | ₹563.00 per share |
| Issue Price (Upper) | ₹386.00 per share | ₹593.00 per share |
| Issue Price (Final) | ₹386.00 per share | ₹593.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 32 shares | 25 shares |
| Fresh Issue Size | 98,32,000 shares | 16,02,023 shares |
| Fresh Issue Size (Amount) | up to ₹379.52 Cr | up to ₹95.00 Cr |
| OFS Issue Size | 0 shares | 1,34,90,726 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹800.00 Cr |
| Issue Size Total | 98,32,000 shares | 1,50,92,749 shares |
| Issue Size Total (Amount) | up to ₹379.52 Cr | up to ₹895.00 Cr |
PNGS Reva Diamond Jewellery IPO opens on Feb 24, 2026, while Sudeep Pharma IPO opens on Nov 21, 2025. The closing date of PNGS Reva Diamond Jewellery IPO and Sudeep Pharma IPO is Feb 26, 2026, and Nov 25, 2025, respectively.
| PNGS Reva Diamond Jewellery IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Feb 23, 2026 | Nov 20, 2025 |
| Issue Open | Feb 24, 2026 | Nov 21, 2025 |
| Issue Close | Feb 26, 2026 | Nov 25, 2025 |
| Basis Of Allotment (Tentative) | Feb 27, 2026 | Nov 26, 2025 |
| Initiation of Refunds (Tentative) | Mar 02, 2026 | Nov 27, 2025 |
| Credit of Share (Tentative) | Mar 02, 2026 | Nov 27, 2025 |
| Listing date (Tentative) | Mar 04, 2026 | Nov 28, 2025 |
| Anchor Lockin End date 1 | Mar 28, 2026 | Dec 26, 2025 |
| Anchor Lockin End date 2 | May 27, 2026 | Feb 24, 2026 |
PNGS Reva Diamond Jewellery IPO P/E ratio is 10.96, as compared to Sudeep Pharma IPO P/E ratio of 47.61.
| PNGS Reva Diamond Jewellery IPO | Sudeep Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)Sudeep Pharma Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.45 | 89.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 60.31 | 76.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.96 | 47.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1224.04 Cr. | ₹6697.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 165.9% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 79.8% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.90 | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹35.21 | ₹12.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 59.36% | 27.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the PNGS Reva Diamond Jewellery IPO Retail Individual Investors (RII) are offered 9,77,216 shares while in Sudeep Pharma IPO retail investors are offered 9,77,216 shares. Qualified Institutional Buyers (QIB) are offered 29,69,600 shares in PNGS Reva Diamond Jewellery IPO and 30,18,550 shares in Sudeep Pharma IPO.
| PNGS Reva Diamond Jewellery IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 44,19,200 shares | 45,27,823 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 29,69,600 shares | 30,18,550 shares |
| NII | 14,56,000 shares | 22,63,913 shares |
| RII | 9,77,216 shares | 52,82,463 shares |
| Employee | 9,984 shares | 0 shares |
| Others | ||
| Total | 98,32,000 shares | 1,50,92,749 shares |
PNGS Reva Diamond Jewellery IPO subscribed 1.30x in total, whereas Sudeep Pharma IPO subscribed 93.71x.
| PNGS Reva Diamond Jewellery IPO | Sudeep Pharma IPO | |
|---|---|---|
| QIB (times) | 1.10x | 213.08x |
| NII (times) | 1.62x | 116.72x |
| Big NII (times) | 1.71x | 134.91x |
| Small NII (times) | 1.44x | 80.33x |
| RII (times) | 1.37x | 15.65x |
| Employee (times) | 7.08x | |
| Other (times) | ||
| Total (times) | 1.30x | 93.71x |
